Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dupilumab in the Treatment of Chronic Rhinosinusitis with Nasal Polyposis
John V Boyle, Kent Lam, Joseph K. Han
Immunotherapy (2020) Vol. 12, Iss. 2, pp. 111-121
Closed Access | Times Cited: 21

Showing 21 citing articles:

Survey on Use of Local and Systemic Corticosteroids in the Management of Chronic Rhinosinusitis with Nasal Polyps: Identification of Unmet Clinical Needs
Eugenio De Corso, Carlotta Pipolo, Elena Cantone, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 6, pp. 897-897
Open Access | Times Cited: 32
Eosinophils—from cradle to grave
Miloš Jeseňák, Zuzana Diamant, Dagmar Simon, et al.
Allergy (2023) Vol. 78, Iss. 12, pp. 3077-3102
Open Access | Times Cited: 18
Linking adipose tissue eosinophils, IL-4, and leptin in human obesity and insulin resistance
James D. Hernandez, Ting Li, Hamza Ghannam, et al.
JCI Insight (2024) Vol. 9, Iss. 3
Open Access | Times Cited: 5
Parasitic infections related to anti-type 2 immunity monoclonal antibodies: a disproportionality analysis in the food and drug administration’s adverse event reporting system (FAERS)
Victor Pera, Guy Brusselle, Sebastian Riemann, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 8
Blood Eosinophilic and Basophilic Trends in Recurring and Non-Recurring Eosinophilic Rhinosinusitis With Nasal Polyps
Giuseppe Brescia, Giacomo Contro, Luciano Giacomelli, et al.
American Journal of Rhinology and Allergy (2020) Vol. 35, Iss. 3, pp. 296-301
Closed Access | Times Cited: 22
Dupilumab Adverse Events in Nasal Polyp Treatment: Analysis of FDA Adverse Event Reporting System
Austin R. Swisher, Rijul S. Kshirsagar, Nithin D. Adappa, et al.
The Laryngoscope (2021) Vol. 132, Iss. 12, pp. 2307-2313
Closed Access | Times Cited: 19
A Comprehensive Review Exploring Allergic Rhinitis With Nasal Polyps: Mechanisms, Management, and Emerging Therapies
Gowtham Narasimhan, Prasad Deshmukh, Sagar S Gaurkar, et al.
Cureus (2024)
Open Access | Times Cited: 2
A case report of allergic fungal rhinosinusitis managed with Dupilumab
Naif H. Alotaibi, Latifa A. Aljasser, Rand Arnaout, et al.
International Journal of Surgery Case Reports (2021) Vol. 88, pp. 106479-106479
Open Access | Times Cited: 14
Dupilumab‐related adverse events among patients with chronic rhinosinusitis with nasal polyposis
Daniel J. Lee, Hannah B. Cramer, Rijul S. Kshirsagar, et al.
International Forum of Allergy & Rhinology (2022) Vol. 13, Iss. 8, pp. 1542-1545
Closed Access | Times Cited: 9
Neutrophil infiltrates and eosinophil aggregates in chronic rhinosinusitis with nasal polyps and EGPA
Giacomo Contro, Giuseppe Brescia, Lara Alessandrini, et al.
Clinical Rheumatology (2020) Vol. 40, Iss. 5, pp. 1949-1957
Closed Access | Times Cited: 12
Superficial Conjunctival Cells from Dupilumab-treated Atopic Dermatitis Patients with Ocular Adverse Events Display a Transcriptomic Psoriasis Signature
Myriam Cassagne, Stéphane Galiacy, Anna Kychygina, et al.
Journal of Investigative Dermatology (2024)
Open Access | Times Cited: 1
Successful Use of Dupilumab as a Salvage Therapy for Recalcitrant Allergic Fungal Rhinosinusitis: A Case Report
Revan A Mujahed, Osama Marglani, Lama S Maksood, et al.
Cureus (2022)
Open Access | Times Cited: 7
TAS2R38 Bitter Taste Receptor Expression in Chronic Rhinosinusitis with Nasal Polyps: New Data on Polypoid Tissue
Joanna Jeruzal-Świątecka, Edyta Borkowska, Mateusz Łaszczych, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 13, pp. 7345-7345
Open Access | Times Cited: 6
Eosinophils as potential mediators of autoimmunity in eosinophilic lung disease
Manali Mukherjee, Parameswaran Nair
European Respiratory Society eBooks (2022)
Closed Access | Times Cited: 4
CD4+ and CD8+ T cells infiltration of the polyp tissue in a series of Greek patients with chronic rhinosinusitis with nasal polyps
Spyridon Gougousis, Kalliopi Domvri, Κonstantinos Porpodis, et al.
European Journal of Inflammation (2021) Vol. 19
Closed Access | Times Cited: 4
Biological therapy in atopic diseases
Iva Mrkić Kobal, Mirjana Turkalj, Teška Astma, et al.
Liječnički vjesnik (2024) Vol. 146, Iss. Supp 1
Open Access
The role of omalizumab in the treatment of chronic rhinosinusitis with nasal polyposis
Jeffrey P. Aldinger, T Dobyns, Kent Lam, et al.
Expert Opinion on Biological Therapy (2021) Vol. 21, Iss. 9, pp. 1143-1149
Closed Access | Times Cited: 3
Biomarkers in Otorhinolaryngology
Ayşe Pelin Yiğider, Özgür Yiğit
BENTHAM SCIENCE PUBLISHERS eBooks (2022), pp. 276-308
Closed Access | Times Cited: 1
Chronic rhinosinusitis is not associated with increased incidence of acute myocardial infarction: A national population-based study
Hyun Jung Kim, Hyeong Sik Ahn, Ji‐Hun Mo, et al.
PLoS ONE (2023) Vol. 18, Iss. 9, pp. e0286048-e0286048
Open Access
The Simultaneous Inhibition of IL‑4 and IL‑13 by Dupilumab
Ana Paula Galli Sanchez, Tatiane Ester Aidar Fernandes
Journal of Clinical Research in Dermatology (2021) Vol. 8, Iss. 2, pp. 1-4
Open Access
Mepolizumab as Anti-interleukin-5 Therapy for Chronic Rhinosinusitis with Nasal Polyposis
Matthew Lelegren, Sara A. Sun, Joseph K. Han, et al.
touchREVIEWS in Respiratory & Pulmonary Diseases (2021) Vol. 6, Iss. 1, pp. 42-42
Open Access
Page 1

Scroll to top